{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T22:33:29Z","timestamp":1792967609497,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","award":["517483"],"award-info":[{"award-number":["517483"]}],"id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Attention-deficit hyperactivity disorder (ADHD) is associated with a higher risk of premature mortality compared to the general population, although reported risks vary. The aim of this paper was to review studies that have examined associations between premature mortality and ADHD and consider factors that could explain variation in risk estimates. A literature search was carried out using online databases (PMC, OVID, and Scopus library) to identify relevant articles. We then considered: sample ascertainment, sample size, method of diagnosing ADHD and age at diagnosis, sex, age range for mortality data, hazard ratio\/ mortality rate ratio (95% confidence interval), sample size, and cause of death, as factors that could explain variation in risk estimates. We focus on nine papers that report risk of all-cause mortality in population samples via hazard ratios, odds ratios, and mortality ratios, which varied from 1.07 to 4.44. Higher risk estimates were found in studies that followed up to older ages and among individuals who were female, diagnosed with ADHD later, and had psychiatric comorbidity. Most follow up found non-natural causes (e.g. suicide, accidents) to be the most prevalent cause of death but studies with longer follow up suggested that non-natural causes may be more important in older individuals. Evidence suggests that ADHD medication reduces the risk of premature mortality but findings are clearer for stimulant than for non-stimulant medication. Clinicians need to be aware that females with ADHD, those with a delayed ADHD diagnosis and who show psychiatric comorbidity are at highest risk of premature mortality. However prescribing ADHD medication may reduce this risk.<\/jats:p>","DOI":"10.1007\/s00787-026-03156-7","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:51:04Z","timestamp":1785991864000},"page":"3117-3128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attention deficit hyperactivity disorder (ADHD) and premature mortality: A narrative review of the literature"],"prefix":"10.1007","volume":"35","author":[{"given":"Yasmin","family":"Rahali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7493-2041","authenticated-orcid":false,"given":"Charlotte A.","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3689-737X","authenticated-orcid":false,"given":"Anita","family":"Thapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-8833","authenticated-orcid":false,"given":"Ajay K.","family":"Thapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"3156_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ije\/dyt261","volume":"43","author":"GV Polanczyk","year":"2014","unstructured":"Polanczyk GV, Willcutt EG, Salum GA et al (2014) ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 43:434\u2013442. https:\/\/doi.org\/10.1093\/ije\/dyt261","journal-title":"Int J Epidemiol"},{"key":"3156_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S2215-0366(17)30167-0","volume":"5","author":"K Sayal","year":"2018","unstructured":"Sayal K, Prasad V, Daley D et al (2018) ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry 5:175\u2013186. https:\/\/doi.org\/10.1016\/S2215-0366(17)30167-0","journal-title":"Lancet Psychiatry"},{"key":"3156_CR3","doi-asserted-by":"publisher","first-page":"115449","DOI":"10.1016\/j.psychres.2023.115449","volume":"328","author":"G Ayano","year":"2023","unstructured":"Ayano G, Tsegay L, Gizachew Y et al (2023) Prevalence of attention deficit hyperactivity disorder in adults: Umbrella review of evidence generated across the globe. Psychiatry Res 328:115449. https:\/\/doi.org\/10.1016\/j.psychres.2023.115449","journal-title":"Psychiatry Res"},{"key":"3156_CR4","doi-asserted-by":"publisher","unstructured":"French B, Nalbant G, Wright H et al (2024) The impacts associated with having ADHD: an umbrella review. Front Psychiatry 15. https:\/\/doi.org\/10.3389\/fpsyt.2024.1343314","DOI":"10.3389\/fpsyt.2024.1343314"},{"key":"3156_CR5","doi-asserted-by":"publisher","first-page":"e198714","DOI":"10.1001\/jamanetworkopen.2019.8714","volume":"2","author":"VC-H Chen","year":"2019","unstructured":"Chen VC-H, Chan H-L, Wu S-I et al (2019) Attention-Deficit\/Hyperactivity Disorder and Mortality Risk in Taiwan. JAMA Netw Open 2:e198714. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.8714","journal-title":"JAMA Netw Open"},{"key":"3156_CR6","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","volume":"385","author":"S Dalsgaard","year":"2015","unstructured":"Dalsgaard S, \u00d8stergaard SD, Leckman JF et al (2015) Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet Lond Engl 385:2190\u20132196. https:\/\/doi.org\/10.1016\/S0140-6736(14)61684-6","journal-title":"Lancet Lond Engl"},{"key":"3156_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ypmed.2016.06.021","volume":"90","author":"AS London","year":"2016","unstructured":"London AS, Landes SD (2016) Attention Deficit Hyperactivity Disorder and adult mortality. Prev Med 90:8\u201310. https:\/\/doi.org\/10.1016\/j.ypmed.2016.06.021","journal-title":"Prev Med"},{"key":"3156_CR8","doi-asserted-by":"publisher","first-page":"e216401","DOI":"10.1001\/jamapediatrics.2021.6401","volume":"176","author":"F Catal\u00e1-L\u00f3pez","year":"2022","unstructured":"Catal\u00e1-L\u00f3pez F, Hutton B, Page MJ et al (2022) Mortality in Persons With Autism Spectrum Disorder or Attention-Deficit\/Hyperactivity Disorder: A Systematic Review and Meta-analysis. JAMA Pediatr 176:e216401. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.6401","journal-title":"JAMA Pediatr"},{"key":"3156_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.2024.199","volume":"226","author":"E O\u2019Nions","year":"2025","unstructured":"O\u2019Nions E, El Baou C, John A et al (2025) Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study. Br J Psychiatry J Ment Sci 226:1\u20138. https:\/\/doi.org\/10.1192\/bjp.2024.199","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"3156_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1192\/bjp.2023.90","volume":"223","author":"AK Thapar","year":"2023","unstructured":"Thapar AK, Riglin L, Blakey R et al (2023) Childhood attention-deficit hyperactivity disorder problems and mid-life cardiovascular risk: prospective population cohort study. Br J Psychiatry 223:472\u2013477. https:\/\/doi.org\/10.1192\/bjp.2023.90","journal-title":"Br J Psychiatry"},{"key":"3156_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41398-024-02825-y","volume":"14","author":"H-M Vasiliadis","year":"2024","unstructured":"Vasiliadis H-M, Lunghi C, Rahme E et al (2024) ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study. Transl Psychiatry 14:128. https:\/\/doi.org\/10.1038\/s41398-024-02825-y","journal-title":"Transl Psychiatry"},{"key":"3156_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1001\/jama.2024.0851","volume":"331","author":"L Li","year":"2024","unstructured":"Li L, Zhu N, Zhang L et al (2024) ADHD Pharmacotherapy and Mortality in Individuals With ADHD. JAMA 331:850\u2013860. https:\/\/doi.org\/10.1001\/jama.2024.0851","journal-title":"JAMA"},{"key":"3156_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S (2019) SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 4:5. https:\/\/doi.org\/10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"3156_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1542\/peds.2012-2354","volume":"131","author":"WJ Barbaresi","year":"2013","unstructured":"Barbaresi WJ, Colligan RC, Weaver AL et al (2013) Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics 131:637\u2013644. https:\/\/doi.org\/10.1542\/peds.2012-2354","journal-title":"Pediatrics"},{"key":"3156_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamapsychiatry.2019.1944","volume":"76","author":"S Sun","year":"2019","unstructured":"Sun S, Kuja-Halkola R, Faraone SV et al (2019) Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit\/Hyperactivity Disorder. JAMA Psychiatry 76:1141\u20131149. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.1944","journal-title":"JAMA Psychiatry"},{"key":"3156_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/19485565.2021.2020618","volume":"67","author":"AS London","year":"2022","unstructured":"London AS, Landes SD (2022) Attention deficit hyperactivity disorder and the age pattern of adult mortality. Biodemography Soc Biol 67:28\u201339. https:\/\/doi.org\/10.1080\/19485565.2021.2020618","journal-title":"Biodemography Soc Biol"},{"key":"3156_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12888-022-03967-3","volume":"22","author":"N Schiavone","year":"2022","unstructured":"Schiavone N, Virta M, Lepp\u00e4m\u00e4ki S et al (2022) Mortality in individuals with childhood ADHD or subthreshold symptoms - a prospective perinatal risk cohort study over 40 years. BMC Psychiatry 22:325. https:\/\/doi.org\/10.1186\/s12888-022-03967-3","journal-title":"BMC Psychiatry"},{"key":"3156_CR18","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00787-024-02511-w","volume":"34","author":"J-S Jeng","year":"2025","unstructured":"Jeng J-S, Huang H-H, Chang W-H et al (2025) Longitudinal study on all-cause and suicide mortality among individuals with attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 34:1229\u20131238. https:\/\/doi.org\/10.1007\/s00787-024-02511-w","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3156_CR19","doi-asserted-by":"publisher","unstructured":"George A, Stead TS, Ganti L What\u2019s the Risk: Differentiating Risk Ratios, Odds Ratios, and Hazard Ratios? Cureus 12:e10047. https:\/\/doi.org\/10.7759\/cureus.10047","DOI":"10.7759\/cureus.10047"},{"key":"3156_CR20","unstructured":"The NHS England ADHD Taskforce (2025) Report of the independent ADHD Taskforce. NHS England"},{"key":"3156_CR21","unstructured":"Martin J, Rouquette OY, Langley K et al (2025) Antecedents and outcomes of a late attention deficit hyperactivity disorder (ADHD) diagnosis in female 07:25330613. https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/antecedents-and-outcomes-of-a-later-attentiondeficit-hyperactivity-disorder-adhd-diagnosis-in-females\/B07508A57C3472D4AC2BE48432C9FBDC"},{"key":"3156_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/1363461520902885","volume":"57","author":"O Slobodin","year":"2020","unstructured":"Slobodin O, Masalha R (2020) Challenges in ADHD care for ethnic minority children: A review of the current literature. Transcult Psychiatry 57:468\u2013483. https:\/\/doi.org\/10.1177\/1363461520902885","journal-title":"Transcult Psychiatry"},{"key":"3156_CR23","doi-asserted-by":"publisher","first-page":"e0277175","DOI":"10.1371\/journal.pone.0277175","volume":"17","author":"W-S Choi","year":"2022","unstructured":"Choi W-S, Woo YS, Wang S-M et al (2022) The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review. PLoS ONE 17:e0277175. https:\/\/doi.org\/10.1371\/journal.pone.0277175","journal-title":"PLoS ONE"},{"key":"3156_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41380-018-0116-3","volume":"24","author":"A Caye","year":"2019","unstructured":"Caye A, Swanson JM, Coghill D, Rohde LA (2019) Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry 24:390\u2013408. https:\/\/doi.org\/10.1038\/s41380-018-0116-3","journal-title":"Mol Psychiatry"},{"key":"3156_CR25","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20121686","author":"I Brikell","year":"2021","unstructured":"Brikell I, Wimberley T, Albi\u00f1ana C et al (2021) Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD. Am J Psychiatry. https:\/\/doi.org\/10.1176\/appi.ajp.2020.20121686","journal-title":"Am J Psychiatry"},{"key":"3156_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12888-024-05994-8","volume":"24","author":"C Liman","year":"2024","unstructured":"Liman C, Schein J, Wu A et al (2024) Real world analysis of treatment change and response in adults with attention-deficit\/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study in the United States. BMC Psychiatry 24:618. https:\/\/doi.org\/10.1186\/s12888-024-05994-8","journal-title":"BMC Psychiatry"},{"key":"3156_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","volume":"4","author":"C Kuehner","year":"2017","unstructured":"Kuehner C (2017) Why is depression more common among women than among men? Lancet Psychiatry 4:146\u2013158. https:\/\/doi.org\/10.1016\/S2215-0366(16)30263-2","journal-title":"Lancet Psychiatry"},{"key":"3156_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/1087054716676342","volume":"22","author":"K Yoshimasu","year":"2018","unstructured":"Yoshimasu K, Barbaresi WJ, Colligan RC et al (2018) Adults With Persistent ADHD: Gender and Psychiatric Comorbidities-A Population-Based Longitudinal Study. J Atten Disord 22:535\u2013546. https:\/\/doi.org\/10.1177\/1087054716676342","journal-title":"J Atten Disord"},{"key":"3156_CR29","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/jcpp.13920","volume":"65","author":"C Skoglund","year":"2024","unstructured":"Skoglund C, Sundstr\u00f6m Poromaa I, Leksell D et al (2024) Time after time: failure to identify and support females with ADHD - a Swedish population register study. J Child Psychol Psychiatry 65:832\u2013844. https:\/\/doi.org\/10.1111\/jcpp.13920","journal-title":"J Child Psychol Psychiatry"},{"key":"3156_CR30","doi-asserted-by":"publisher","unstructured":"Martin J (2024) Why are females less likely to be diagnosed with ADHD in childhood than males? Lancet Psychiatry 0. https:\/\/doi.org\/10.1016\/S2215-0366(24)00010-5","DOI":"10.1016\/S2215-0366(24)00010-5"},{"key":"3156_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1087054707299597","volume":"10","author":"L Castle","year":"2007","unstructured":"Castle L, Aubert RE, Verbrugge RR et al (2007) Trends in medication treatment for ADHD. J Atten Disord 10:335\u2013342. https:\/\/doi.org\/10.1177\/1087054707299597","journal-title":"J Atten Disord"},{"key":"3156_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00787-018-1211-3","volume":"28","author":"FD Mowlem","year":"2019","unstructured":"Mowlem FD, Rosenqvist MA, Martin J et al (2019) Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. Eur Child Adolesc Psychiatry 28:481\u2013489. https:\/\/doi.org\/10.1007\/s00787-018-1211-3","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3156_CR33","doi-asserted-by":"publisher","unstructured":"Chen VC-H, Chan H-L, Wu S-I et al (2020) Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: population-based cohort study. Br J Psychiatry :1\u20139. https:\/\/doi.org\/10.1192\/bjp.2020.129","DOI":"10.1192\/bjp.2020.129"},{"key":"3156_CR34","unstructured":"National Institute for Health and Care Excellence (2018) Attention deficit hyperactivity disorder: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng87\/chapter\/Recommendations#medication. Accessed 3 June 2026"},{"key":"3156_CR35","doi-asserted-by":"publisher","first-page":"116309","DOI":"10.1016\/j.psychres.2024.116309","volume":"344","author":"H-M Vasiliadis","year":"2025","unstructured":"Vasiliadis H-M, Rochette L, Massamba V et al (2025) Association between stimulant and non-stimulant ADHD medications and completed suicide in adolescents and adults: A population-based nested case-control study. Psychiatry Res 344:116309. https:\/\/doi.org\/10.1016\/j.psychres.2024.116309","journal-title":"Psychiatry Res"},{"key":"3156_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopsych.2019.12.003","volume":"88","author":"Z Chang","year":"2020","unstructured":"Chang Z, Quinn PD, O\u2019Reilly L et al (2020) Medication for Attention-Deficit\/Hyperactivity Disorder and Risk for Suicide Attempts. Biol Psychiatry 88:452\u2013458. https:\/\/doi.org\/10.1016\/j.biopsych.2019.12.003","journal-title":"Biol Psychiatry"},{"key":"3156_CR37","doi-asserted-by":"publisher","unstructured":"Chan JKN, Correll CU, Wong CSM et al (2023) Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis. . eClinicalMedicine 65. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102294","DOI":"10.1016\/j.eclinm.2023.102294"},{"key":"3156_CR38","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1177\/10870547231176862","volume":"27","author":"B French","year":"2023","unstructured":"French B, Daley D, Groom M, Cassidy S (2023) Risks Associated With Undiagnosed ADHD and\/or Autism: A Mixed-Method Systematic Review. J Atten Disord 27:1393\u20131410. https:\/\/doi.org\/10.1177\/10870547231176862","journal-title":"J Atten Disord"},{"key":"3156_CR39","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S2215-0366(15)00271-0","volume":"2","author":"S Dalsgaard","year":"2015","unstructured":"Dalsgaard S, Leckman JF, Mortensen PB et al (2015) Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. Lancet Psychiatry 2:702\u2013709. https:\/\/doi.org\/10.1016\/S2215-0366(15)00271-0","journal-title":"Lancet Psychiatry"},{"key":"3156_CR40","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.biopsych.2016.02.018","volume":"80","author":"Z Chang","year":"2016","unstructured":"Chang Z, D\u2019Onofrio BM, Quinn PD et al (2016) Medication for Attention-Deficit\/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study. Biol Psychiatry 80:916\u2013922. https:\/\/doi.org\/10.1016\/j.biopsych.2016.02.018","journal-title":"Biol Psychiatry"},{"key":"3156_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1542\/peds.111.1.179","volume":"111","author":"TE Wilens","year":"2003","unstructured":"Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003) Does Stimulant Therapy of Attention-Deficit\/Hyperactivity Disorder Beget Later Substance Abuse? A Meta-analytic Review of the Literature. Pediatrics 111:179\u2013185. https:\/\/doi.org\/10.1542\/peds.111.1.179","journal-title":"Pediatrics"},{"key":"3156_CR42","doi-asserted-by":"publisher","first-page":"e226815","DOI":"10.1001\/jamanetworkopen.2022.6815","volume":"5","author":"L Li","year":"2022","unstructured":"Li L, Chang Z, Sun J et al (2022) Association Between Pharmacological Treatment of Attention-Deficit\/Hyperactivity Disorder and Long-term Unemployment Among Working-Age Individuals in Sweden. JAMA Netw Open 5:e226815. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.6815","journal-title":"JAMA Netw Open"},{"key":"3156_CR43","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa1203241","volume":"367","author":"P Lichtenstein","year":"2012","unstructured":"Lichtenstein P, Halldner L, Zetterqvist J et al (2012) Medication for Attention Deficit\u2013Hyperactivity Disorder and Criminality. N Engl J Med 367:2006\u20132014. https:\/\/doi.org\/10.1056\/NEJMoa1203241","journal-title":"N Engl J Med"},{"key":"3156_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1087054714566076","volume":"24","author":"LE Arnold","year":"2020","unstructured":"Arnold LE, Hodgkins P, Kahle J et al (2020) Long-Term Outcomes of ADHD: Academic Achievement and Performance. J Atten Disord 24:73\u201385. https:\/\/doi.org\/10.1177\/1087054714566076","journal-title":"J Atten Disord"},{"key":"3156_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1087054716669589","volume":"22","author":"JT Instanes","year":"2018","unstructured":"Instanes JT, Klungs\u00f8yr K, Halm\u00f8y A et al (2018) Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review. J Atten Disord 22:203\u2013228. https:\/\/doi.org\/10.1177\/1087054716669589","journal-title":"J Atten Disord"},{"key":"3156_CR46","first-page":"21098","volume":"119","author":"E Du Rietz","year":"2022","unstructured":"Du Rietz E, Butwicka A, Lundstr\u00f6m S, Larsson H (2022) [ADHD, somatic comorbidities and lifestyle factors]. Lakartidningen 119:21098","journal-title":"Lakartidningen"},{"key":"3156_CR47","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/wps.21020","volume":"21","author":"L Li","year":"2022","unstructured":"Li L, Chang Z, Sun J et al (2022) Attention-deficit\/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study. World Psychiatry Off J World Psychiatr Assoc WPA 21:452\u2013459. https:\/\/doi.org\/10.1002\/wps.21020","journal-title":"World Psychiatry Off J World Psychiatr Assoc WPA"},{"key":"3156_CR48","doi-asserted-by":"publisher","unstructured":"Thapar AK, Collishaw S, Davey Smith G et al (2026) Association between childhood ADHD problems and premature mortality: identifying modifiable cardiovascular mechanisms in a UK population cohort. Front Psychiatry 17. https:\/\/doi.org\/10.3389\/fpsyt.2026.1764335","DOI":"10.3389\/fpsyt.2026.1764335"},{"key":"3156_CR49","doi-asserted-by":"publisher","first-page":"e2243597","DOI":"10.1001\/jamanetworkopen.2022.43597","volume":"5","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yao H, Li L et al (2022) Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit\/Hyperactivity Disorder: A Systematic Review and Meta-analysis. JAMA Netw Open 5:e2243597. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.43597","journal-title":"JAMA Netw Open"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03156-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03156-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03156-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T22:01:01Z","timestamp":1792965661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03156-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3156"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-03156-7","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AT was chair of the NHS-E commissioned independent ADHD Taskforce (unpaid role).","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used Elicit in order to identify any studies that may have been missed by initial database searches, as described in the methods. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article","order":2,"name":"Ethics","label":"AI","group":{"name":"EthicsHeading","label":"Declarations"}}]}}